Cigna Group

CI Healthcare Healthcare Plans

Cigna Group’s revenue for fiscal 2025 (year ended December 2025) was $274.9 billion, up 11.2% from fiscal 2024. In the quarter to June 2026, revenue grew 6.68%, EPS grew 10.2%, free cash flow grew 66.9% and total debt rose 3.61%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten; insiders bought in the last twelve months.

302.30 3.49 +1.17%
Market cap
$79.0B
P/E
12.5×
Fwd P/E
11.4×
Dividend yield
2.05%
F-score
8/9
Altman Z
2.62
Beneish M
−2.47
Dividend safety
82/100

Cigna Group (CI) EV/EBITDA

Alert me on EV/EBITDA

As of 16 October 2026, Cigna Group (CI) trades at a EV/EBITDA of 8.3×. Over the past ten years it has ranged from 7.0× (March 2020) to 18.1× (January 2019); the current reading is higher than 9% of that period. That is below the Healthcare Plans industry median of 11.5× and below the Healthcare sector median of 9.2×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 8.1× (2.81%)
FY2024 8.4× (15.41%)
FY2023 9.9× (9.83%)
FY2022 10.9× 12.02%
FY2021 9.8× 8.47%
FY2020 9.0× (3.62%)
FY2019 9.4× (46.89%)
FY2018 17.6× 48.92%
FY2017 11.8× 19.75%
FY2016 9.9× (5.08%)

Quarterly newest first

Period EV/EBITDA Change
Jun 2026 7.7× 1.57%
Mar 2026 7.6× (6.19%)
Dec 2025 8.1× (9.05%)
Sep 2025 8.9× (8.92%)
42 more quarters

Against its own ten years

Low 7.0× High 18.1×
Ten-year median 9.7×
Current reading's percentile 9

EV/EBITDA against peers

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on CI